Novartis Webinar: Carrier screening and prenatal diagnosis of SMA in the post-treatment era - 26 August 2025

Recent advances have enabled earlier detection and improved clinical outcomes in patients with spinal muscular atrophy (SMA). Obstetricians, midwives, and genetic counsellors play a critical role in supporting SMA carrier couples to make informed decisions in pregnancy.

This webinar is based on resources and support available in Australia, and will include:

• Diagnosis pathways and timing of testing
• Available treatments and clinical outcomes
• Role of obstetricians, midwives, and genetic counsellors in prenatal testing
• A case study to discuss the resources available to SMA carrier couples at key decision points of pregnancy

To view a recording of this webinar, please follow this link: Industry webinars

Novartis has developed a summary of the HGSA webinar on SMA carrier screeining. Please see the attached - NOZO37058W HGSA symposium 2025 summary